Literature DB >> 33273060

COVID-19 vaccine trial ethics once we have efficacious vaccines.

David Wendler1, Jorge Ochoa2, Joseph Millum2,3, Christine Grady2, Holly A Taylor2.   

Abstract

Entities:  

Year:  2020        PMID： 33273060     DOI： 10.1126/science.abf5084

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  19 in total

1.  Cost-utility-safety analysis of alternative intradermal versus classical intramuscular COVID-19 vaccination.

Authors:  Rujittika Mungmunpuntipantip; Viroj Wiwanitkit
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-04-15

Review 2.  COVID-19: vaccination problems.

Authors:  Harald Brüssow
Journal:  Environ Microbiol       Date:  2021-05-14       Impact factor: 5.476

3.  Assessing vaccine durability in randomized trials following placebo crossover.

Authors:  Jonathan Fintzi; Dean Follmann
Journal:  Stat Med       Date:  2021-04-29       Impact factor: 2.497

4.  The Essential Role of Data and Safety Monitoring Boards (DSMBs) in Ensuring the Ethics of Global Vaccine Trials to Address Coronavirus Disease 2019 (COVID-19O).

Authors:  Lisa Eckstein; Annette Rid; Dorcas Kamuya; Seema K Shah
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

5.  Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests.

Authors:  Nir Eyal; Tobias Gerhard; Brian L Strom
Journal:  Vaccine       Date:  2021-04-30       Impact factor: 3.641

6.  How to Test Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Ethically Even After One Is Available.

Authors:  Nir Eyal; Marc Lipsitch
Journal:  Clin Infect Dis       Date:  2021-12-16       Impact factor: 9.079

7.  Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials.

Authors:  Dean Follmann; Jonathan Fintzi; Michael P Fay; Holly E Janes; Lindsey Baden; Hana El Sahly; Thomas R Fleming; Devan V Mehrotra; Lindsay N Carpp; Michal Juraska; David Benkeser; Deborah Donnell; Youyi Fong; Shu Han; Ian Hirsch; Ying Huang; Yunda Huang; Ollivier Hyrien; Alex Luedtke; Marco Carone; Martha Nason; An Vandebosch; Honghong Zhou; Iksung Cho; Erin Gabriel; James G Kublin; Myron S Cohen; Lawrence Corey; Peter B Gilbert; Kathleen M Neuzil
Journal:  medRxiv       Date:  2020-12-14

Review 8.  Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities.

Authors:  Rafael Dal-Ré; Linda-Gail Bekker; Christian Gluud; Søren Holm; Vivekanand Jha; Gregory A Poland; Frits R Rosendaal; Brigitte Schwarzer-Daum; Esperança Sevene; Halidou Tinto; Teck Chuan Voo; Nadarajah Sreeharan
Journal:  Lancet Infect Dis       Date:  2021-05-18       Impact factor: 25.071

9.  Next steps for efficacy evaluation in clinical trials of COVID-19 vaccines.

Authors:  Hu-Dachuan Jiang; Li Zhang; Jing-Xin Li; Feng-Cai Zhu
Journal:  Engineering (Beijing)       Date:  2021-05-19       Impact factor: 7.553

10.  Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants.

Authors:  Jenna Rose Stoehr; Alireza Hamidian Jahromi; Clayton Thomason
Journal:  Front Public Health       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.